Lunchtime Laughter for Alzheimer’s Caregivers

By Commentary, Community Events, COVID-19

We could all use a laugh in these uncertain times. If you’re a person with Alzheimer’s disease, a family member, or caregiver, you can join LaughterOnCall for their virtual Lunchtime Laughter meetings, Monday-Friday at 12 PM PST. This webinar offers a light-hearted, engaging way to laugh and cope with feelings of isolation that can come from social distancing.    To register, visit https://zoom.us/meeting/register/uZEtdemurzIq_pN_HCQ7TY2I8cpa4NsoGQ OR e-mail info@laughteroncall.com to sign up. LaughterOnCall may record these meetings for quality purposes. Related posts: Focus on Aging: Federal Partners’ Webinar Series We’re pleased to announce the “Focus on Aging” webinar series with the Administration for Community…

Read More

Focus on Aging: Federal Partners’ Webinar Series

By Commentary, Community Events, COVID-19

We’re pleased to announce the “Focus on Aging” webinar series with the Administration for Community Living, the Centers for Disease Control and Prevention, the Health Resources and Services Administration, and the National Institute on Aging. The first webinar, “Supporting Older Adults in Emergencies: Preparedness, Response, and Recovery” will be held May 13 at 1:30-3:00 p.m. ET. Register today! https://www.nia.nih.gov/alzheimers/focus-aging-federal-partners-webinar-series   A message from: Nina Silverberg, PhD Director, Alzheimer’s Disease Centers Program Division of Neuroscience National Institute on Aging National Institutes of Health Related posts: Lunchtime Laughter for Alzheimer’s Caregivers We could all use a laugh in these uncertain times. If…

Read More

Coronavirus Antibody Tests: Can You Trust the Results?

By Commentary, COVID-19, In the News

Contributed by Edwin Monuki, MD, PhD, Warren L. Bostick Professor and Chair of Pathology and Laboratory Medicine at UC Irvine A recent article in the The New York Times focuses on an issue of grave concern among US health care providers – the flood of unapproved “lateral flow” tests for detecting COVID-19 antibodies. This flood resulted from an FDA decision to allow antibody testing without their usual approval process in order to accelerate the national response to COVID-19. Unfortunately (and not surprisingly), this also resulted in an antibody testing market that one interviewee in the NYT article called the “Wild West”….

Read More

FDA Gives Emergency Authorization For Some COVID-19 Patients To Use Remdesivir

By COVID-19, In the News

NPR reports May 1, 2020 4:22 PM ET – The Food and Drug Administration has given emergency use authorization to the antiviral drug remdesivir to treat hospitalized patients with the coronavirus, President Trump on Friday told reporters at the White House. Gilead CEO Daniel O’Day said remdesivir maker Gilead Sciences is donating 1.5 million vials of the drug and will work with the federal government to distribute it to patients in need… Related posts: Q&A on COVID-19 and Down Syndrome … Campus labs making sample-preserving fluid for COVID-19 test kits … UCI and UCI Health launch comprehensive COVID-19 resource site The UCI…

Read More

VIDEO: Alzheimer’s disease, clinical trials, and COVID-19 with Dr. Daniel Gillen

By Commentary, Community Events, COVID-19

Related posts: VIDEO: Message from our Associate Director of Education, Chelsea Cox … Join the CA Dept. of Aging on April 22 for a Caring for Family & Friends Check-In Call A message from the CA Department of Aging: Join us April 22 for a Caring for Family & Friends Check-In Call: Caregiving from Afar Are You Caring for Family or Friends from Afar During COVID-19? Whether you are providing support to an older person across town, across the country, or… Alzheimer’s disease, clinical trials, & COVID-19: Q&A with Dr. Daniel Gillen Alzheimer’s disease, clinical trials, and COVID-19 Join UCI…

Read More

Health and Human Services launches telehealth resource

By Commentary, COVID-19

HHS launched https://telehealth.hhs.gov. This site is a central source of information on telehealth resources and tools for patients and providers. Related posts: Campus labs making sample-preserving fluid for COVID-19 test kits … Adapting to changes in my day-to-day life Contributed by Bill Edwards, UCI MIND Leadership Council and Speakers Bureau Member, former Alzheimer’s Caregiver, CEO and Global Advisor for Edwards Global Services, Inc. “It is not the strongest or the most intelligent who will survive but those who can best manage change.” Charles Darwin As a father, grandfather, business owner,… UCI and UCI Health launch comprehensive COVID-19 resource site The UCI…

Read More

CDC Adds Six New COVID-19 Symptoms

By Commentary, COVID-19

Over the weekend, the CDC added six new coronavirus symptoms to its list. The new symptoms include chills, repeated shaking with chills, muscle pain, headache, sore throat and a loss of taste or smell.   Watch for symptoms People with COVID-19 have had a wide range of symptoms reported – ranging from mild symptoms to severe illness. Symptoms may appear 2-14 days after exposure to the virus. People with these symptoms or combinations of symptoms may have COVID-19: Cough Shortness of breath or difficulty breathing Or at least two of these symptoms: Fever Chills Repeated shaking with chills Muscle pain…

Read More

Alzheimer’s disease, clinical trials, & COVID-19: Q&A with Dr. Daniel Gillen

By Commentary, Community Events, COVID-19

Alzheimer’s disease, clinical trials, and COVID-19 Join UCI MIND for a live Q&A on Facebook with Dr. Daniel Gillen, Professor and Chair of Statistics at UC Irvine, this Friday, May 1st at 11:00-11:30 AM PST. About the Speaker: Daniel Gillen received his PhD in Biostatistics from the University of Washington and leads the Data Management and Statistics Core for UCI MIND’s NIH-designated Alzheimer’s Disease Research Center. He is an elected fellow of the American Statistical Association and widely recognized for his work in the design and analysis of clinical trials for Alzheimer’s disease and other health conditions. Dr. Gillen serves…

Read More

New hotline for In-Home Supportive Services recipients

By Commentary, COVID-19

The County of Orange Social Services Agency (SSA) announced the creation of a hotline for current In-Home Supportive Services (IHSS) recipients. The hotline staff will be available to discuss recipients’ urgent needs during the coronavirus pandemic. Recipients can call (714) 825-3000 and press option 4. Related posts: Chemistry faculty launch antiviral research project … Alzheimer’s disease, clinical trials, & COVID-19: Q&A with Dr. Daniel Gillen Alzheimer’s disease, clinical trials, and COVID-19 Join UCI MIND for a live Q&A on Facebook with Dr. Daniel Gillen, Professor and Chair of Statistics at UC Irvine, this Friday, May 1st at 11:00-11:30 AM PST….

Read More

VIDEO: Laboratory Research Update – Nicole Schartz, PhD

By Commentary, COVID-19, In the News

Nicole Schartz, PhD, a postdoctoral scholar in Dr. Andrea Tenner’s lab, shares her experience of what’s happening in her lab and her perspective on the pandemic.  Dr. Schartz is also a member of REMIND. Research and Education in Memory Impairments and Neurological Disorders, or REMIND, is a campus organization led by UCI MIND predoctoral and postdoctoral trainees. It aims to encourage collaboration among the next generation of scientists and clinicians, and promote community outreach and education on neurodegenerative diseases. Related posts: Campus labs making sample-preserving fluid for COVID-19 test kits … Join the CA Dept. of Aging on April 22…

Read More